Vakharia, Paras P.
Silverberg, Jonathan I.
Funding for this research was provided by:
Agency for Healthcare Research and Quality
Dermatology Foundation
Article History
First Online: 29 August 2017
Compliance with Ethical Standards
:
: Paras Vakharia has no relevant disclosures or conflict of interests. Jonathan Silverberg has been an investigator for Abbvie, Celgene, Chugai, Eli Lilly, Galderma, GlaxoSmithKline, Realm, Regeneron-Sanofi; consultant for Abbvie, Anacor, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Menlo, Pfizer, Realm, Regeneron-Sanofi; and speaker for Regeneron-Sanofi.
: This publication was made possible with support from the Agency for Healthcare Research and Quality (AHRQ), Grant number K12 HS023011, and the Dermatology Foundation.